[1]
“Anti-Tubercular Drug Regimens and associated Adverse Events: Systematic Review of Studies in India on Tuberculosis Treatments”, Bangladesh J Med Sci, vol. 24, no. 4, pp. 1079–1092, Nov. 2025, doi: 10.3329/bjms.v24i4.84672.